Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retained Vitrectomy Valved Cannulas.

Ophthalmic surgery, lasers & imaging retina·2026
Same author

Retinal and choroidal optical coherence tomography findings in gestational diabetes mellitus: a systematic review and meta-analysis.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Comparison of Intravitreal Antivascular Endothelial Growth Factor Therapy in Treatment-Naïve vs Panretinal Photocoagulation-Treated Eyes With Proliferative Diabetic Retinopathy.

Journal of vitreoretinal diseases·2026
Same author

The Development of Choroidal Osteoma in an Eye with Punctate Inner Choroidopathy: A Case Report and Review of Literature.

International medical case reports journal·2026
Same author

Surgical Management and Outcomes of Large High Myopic Macular Holes: Global Macular Hole Multicenter Study 3.

Retina (Philadelphia, Pa.)·2026
Same author

Optical coherence tomography measurements in retinopathy of prematurity: A systematic review and meta-analysis.

European journal of ophthalmology·2026

Related Experiment Video

Updated: May 24, 2026

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

Update on sympathetic ophthalmia.

J Fernando Arevalo1, Reinaldo A Garcia, Hassan A Al-Dhibi

  • 1Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Middle East African Journal of Ophthalmology
|February 21, 2012
PubMed
Summary

Sympathetic ophthalmia (SO) is a rare but serious inflammation affecting both eyes after injury or surgery to one. Early diagnosis and treatment with corticosteroids or immunosuppressants are crucial for preserving vision.

Keywords:
Dalen–Fuchs NodulesDiffuse Granulomatous Intraocular InflammationOcular Autoimmune-Associated DiseaseOcular TraumaSympathetic Ophthalmia

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Related Experiment Videos

Last Updated: May 24, 2026

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Area of Science:

  • Ophthalmology
  • Immunology

Background:

  • Sympathetic ophthalmia (SO) is a bilateral granulomatous uveitis.
  • It typically arises after ocular trauma or surgery.
  • Incidence is low but significant, especially after vitreoretinal procedures.

Purpose of the Study:

  • To summarize the clinical presentation, diagnosis, and management of sympathetic ophthalmia.
  • To highlight the importance of timely intervention in preventing vision loss.

Main Methods:

  • Clinical findings are the primary diagnostic basis.
  • Diagnosis relies on characteristic signs of bilateral uveitis.

Main Results:

  • SO presents insidiously with blurred vision, pain, and photophobia in the unaffected eye.
  • Key signs include conjunctival injection and granulomatous anterior chamber reactions with mutton-fat keratic precipitates.
  • Posterior segment inflammation can be variable.

Conclusions:

  • Systemic corticosteroids are the primary treatment for SO.
  • Immunosuppressive agents like cyclosporine or azathioprine are used for refractory cases or steroid intolerance.
  • Prompt treatment is essential to manage this sight-threatening condition.